| |
| |
|
| Insider
Information: |
Costa Santo J |
| Relationship: |
Director |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
29,746 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$979,050 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,746 |
|
|
| Total
Value |
$979,050 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 46.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
Director |
2004-01-06 |
5,600 |
2003-09-11 |
0 |
Premium* |
|
|
CV Therapeutics Inc |
CVTX |
Director |
2009-04-06 |
9,146 |
2009-04-06 |
0 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
Director |
2023-05-10 |
15,000 |
2017-08-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
Director |
• • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
• • – |
2022-09-01 |
4 |
AS |
$52.79 |
$791,850 |
D/D |
(15,000) |
10,000 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
• • – |
2022-09-01 |
4 |
OE |
$9.45 |
$154,050 |
D/D |
15,000 |
25,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2022-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2022-03-02 |
4 |
S |
$37.35 |
$373,477 |
D/D |
(10,000) |
5,000 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2022-03-02 |
4 |
OE |
$10.68 |
$106,800 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-10-05 |
4 |
OE |
$9.45 |
$141,750 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-10-05 |
4 |
AS |
$30.00 |
$450,000 |
D/D |
(15,000) |
0 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-06-22 |
4 |
S |
$25.00 |
$500,000 |
D/D |
(20,000) |
0 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-06-22 |
4 |
OE |
$7.61 |
$152,200 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-05-11 |
4 |
S |
$19.47 |
$594,687 |
D/D |
(29,999) |
0 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-05-11 |
4 |
OE |
$6.21 |
$254,587 |
D/D |
29,999 |
6,666 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-05-05 |
4 |
S |
$17.00 |
$141,644 |
D/D |
(8,332) |
0 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-05-05 |
4 |
OE |
$5.46 |
$50,992 |
D/D |
8,332 |
4,166 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-31 |
4 |
AS |
$15.00 |
$75,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-31 |
4 |
OE |
$4.44 |
$22,200 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-29 |
4 |
AS |
$14.00 |
$70,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-29 |
4 |
OE |
$4.44 |
$22,200 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Director |
– • – |
2009-04-06 |
4 |
OE |
$8.74 |
$678,500 |
D/D |
50,000 |
17,541 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Director |
– • – |
2009-04-06 |
4 |
D |
$19.93 |
$814,220 |
D/D |
(40,854) |
9,146 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-01-06 |
4 |
A |
$31.60 |
$88,480 |
D/D |
2,800 |
5,600 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2003-09-11 |
4 |
AS |
$31.95 |
$95,835 |
D/D |
(3,000) |
2,800 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2003-09-11 |
4 |
OE |
$9.75 |
$29,250 |
D/D |
3,000 |
5,800 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
